Biovian has announced that Magnus Gustafsson has been appointed Head of Global Business Development.
Gustafsson will be a strong addition to the business and marketing team and will be giving his contribution to the growth acceleration of the company, it states. In his position Gustafsson will be responsible for identifying new business opportunities within both existing and new markets.
“We are very pleased that Magnus Gustafsson will assume the role of Head of Global Business Development at Biovian,” Knut Ringbom, CEO of Biovian, states. “His track record of driving a business with both commercial and strategic success combined with a customer-centric mindset makes Magnus an excellent fit for this important role. We look forward to working with him as we continue to implement Biovian’s objective in turning ideas into products by taking client projects from the laboratory bench to the clinic.”
Prior to joining Biovian Magnus Gustafsson worked as Director Strategy, Search and Evaluation at Cytiva (formerly GE Healthcare Life Sciences). Gustafsson has experience in the CDMO business from his previous role at Cobra Biologics, where he was a member of the Senior Management team and worked as Business and Corporate Development Director during the years of the company’s exponential growth. In addition to a business expertise Magnus Gustafsson brings with him his proficiency in science with more than 20 peer-reviewed articles as well as 15 years of experience in academic collaborations, states Biovian.